Skip to main content
. 2022 Aug 11;13:923585. doi: 10.3389/fphar.2022.923585

TABLE 4.

Local tumor response assessed using mRECIS criteria.

Response 1 month 3 months 6 months
Complete response 4 (19.0%) 5 (29.4%) 3 (27.3%)
Partial response 7 (33.3%) 6 (35.3%) 3 (27.3%)
Stable disease 9 (42.9%) 2 (11.8%) 1 (9.1%)
Progressive disease 1 (4.8%) 4 (23.5%) 4 (36.4%)
Overall response rate 11 (52.4%) 11 (64.7%) 6 (54.5%)
Disease control rate 20 (95.2%) 13 (76.5%) 7 (63.3%)